11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10.
Posts Tagged ‘NASDAQ:CTIC’
CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the CTI BioPharma Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call.
5 Best Performing NASDAQ Stocks in 2022
CTI BioPharma Corp. (NASDAQ:CTIC) was incorporated in 1991 and is headquartered in Seattle, Washington.
12 Best Multibagger Stocks to Buy Now
In this uncertain market backdrop, investors are focused on macroeconomic and geopolitical constraints and their potential effects on investment portfolios.
5 Best Medical Stocks Under $5
In this piece, we will take a look at the five best medical stocks under $5.
5 Biotech Penny Stocks with Growth Catalysts
In this article, we discuss 5 biotech penny stocks with growth catalysts.
5 Penny Stocks That Can Explode in 2022
In this article, we discuss the 5 penny stocks that can explode in 2022.
5 Penny Stocks to Buy in March
CTI BioPharma Corp. (NASDAQ:CTIC) is a biopharmaceutical company based in the United States, developing therapies for blood-related cancers.
Timothy P. Lynch’s Stonepine Capital Portfolio: Top 5 Healthcare Stocks
In this article, we discuss the top 5 healthcare stock picks of Timothy P. Lynch's Stonepine Capital.
5 Pharmaceutical Stocks to Buy According to Timothy Lynch’s Stonepine Capital
In this article, we will discuss the 5 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital based on Q2 2021 holdings of the fund.
5 Best Stocks Under $5 in 2021
Ranking 5th in our list of the 10 best stocks under $5 in 2021 is apparel retail firm Express, Inc. (NYSE: EXPR).
Where Do Hedge Funds Stand On CTI Biopharma Corp. (CTIC)?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are...
Here is What Hedge Funds Think About CTI Biopharma Corp. (CTIC)
In this article we will check out the progression of hedge fund sentiment towards CTI Biopharma Corp. (NASDAQ:CTIC) and determine whether it is a good investment right now.
Is CTI BioPharma Corp. (CTIC) A Good Stock To Buy ?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Hedge Fund and Insider Trading News: Steven Cohen, Starboard Value, Zendesk Inc (ZEN), CTI BioPharma Corp (CTIC), and More
Just as billionaire Steven Cohen stages a comeback as a hedge fund manager, a current employee sued his Point72 Asset Management accusing it of discriminating against women and...
13D Filing: Biotechnology Value Fund LP and CTI Biopharma Corp (CTIC)
You can access the original SEC filing by clicking here.
CTI BioPharma Corp (CTIC): Are Hedge Funds Right About This Stock?
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
5 Biotech Penny Stocks Smart Money Is Piling On
Apart from technology, if there ever was a sector that short sellers were afraid to touch for fear of being squeezed out vehemently, it has to be biotech.
Michael Castor’s Sio Capital Management’s New Bets For This Quarter
The New York-based healthcare fund Sio Capital Management was founded by Dr.
Is CTI BioPharma Corp (CTIC) Going to Burn These Hedge Funds?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Incyte Corporation (INCY), Gilead Sciences, Inc. (GILD): Pop-Worthy Data, Incyte, but Let’s See More
For a subgroup of the patients, the hazard ratio for overall survival in late-stage pancreatic cancer patients taking Incyte Corporation (NASDAQ:INCY)'s Jakafi and Roche's Xeloda...
Sprint Nextel Corporation (S), Cell Therapeutics Inc (CTIC): 5 Companies That Haven’t Earned Their Keep
In order to become a successful investor, it takes a love for finance, quite a bit of discipline, and a long-term mind-set.
Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”
A lot has been written this week -- at The Fool and elsewhere -- about Sarepta Therapeutics Inc (NASDAQ:SRPT)' update on its meeting with the Food and Drug Administration.
